Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CXCL11 ELISA Kit (AC3829)
Cat.#: ASET-2418
Specifications
Description Human CXCL11 ELISA Kit allows for the in vitro quantitative determination of human CXCL11 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 37.5 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 62.5-4000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2417 Rat C Peptide ELISA Kit (AC3828) Quantitative inquiry ASET-1089 Human Profilin 1 ELISA Kit (AC2500) Quantitative inquiry ASET-1693 Human UCP3 ELISA Kit (AC3104) Quantitative inquiry ASET-1312 Bovine Adiponectin ELISA Kit (AC2723) Quantitative inquiry ASET-1393 Human Synaptophysin ELISA Kit (AC2804) Quantitative inquiry ASET-1784 Mouse DLL1 ELISA Kit (AC3195) Quantitative inquiry ASET-2328 Human EPHA10 ELISA Kit (AC3739) Quantitative inquiry ASET-1967 Human Estrogen Receptor beta ELISA Kit (AC3378) Quantitative inquiry ASET-2462 Human Zyxin ELISA Kit (AC3873) Quantitative inquiry ASET-1319 Guinea Pig BDNF ELISA Kit (AC2730) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket